{
    "2020-09-22": [
        [
            {
                "time": "2020-09-22",
                "original_text": "财信证券：医改决心不改 关注具有长期逻辑领域（附股）",
                "features": {
                    "keywords": [
                        "医改",
                        "长期逻辑",
                        "领域"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-22",
                "original_text": "33股遭重要股东减持超亿元 减持股份",
                "features": {
                    "keywords": [
                        "减持",
                        "重要股东",
                        "超亿元"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-22",
                "original_text": "141家公司遭重要股东减持涉及金额123.01亿元（附股） 减持股份",
                "features": {
                    "keywords": [
                        "减持",
                        "重要股东",
                        "123.01亿元"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-22",
                "original_text": "医药行业周报：关注板块回调态势下的疫苗及生物制品",
                "features": {
                    "keywords": [
                        "医药行业",
                        "板块回调",
                        "疫苗",
                        "生物制品"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-22",
                "original_text": "医疗股开盘大幅拉升 博晖创新、拱东医疗涨停 阳普医疗等多股大涨",
                "features": {
                    "keywords": [
                        "医疗股",
                        "拉升",
                        "涨停",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-22",
                "original_text": "医药生物行业32只股上榜百元股，占比25.20%",
                "features": {
                    "keywords": [
                        "医药生物",
                        "百元股",
                        "占比25.20%"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}